Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactions

Small molecule stabilizers of protein–protein interactions hold great therapeutic potential. Based on virtual screening and molecular docking, the authors here develop a strategy to evolve weak, promiscuous inhibitors of 14-3-3 interactions into selective stabilizers of the 14-3-3/ChREBP complex.

Bibliographic Details
Main Authors: Eline Sijbesma, Emira Visser, Kathrin Plitzko, Philipp Thiel, Lech-Gustav Milroy, Markus Kaiser, Luc Brunsveld, Christian Ottmann
Format: Article
Language:English
Published: Nature Publishing Group 2020-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-020-17741-0
id doaj-8ff8fc48608f42e5b0be3c2e5c15b283
record_format Article
spelling doaj-8ff8fc48608f42e5b0be3c2e5c15b2832021-08-08T11:38:22ZengNature Publishing GroupNature Communications2041-17232020-08-011111910.1038/s41467-020-17741-0Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactionsEline Sijbesma0Emira Visser1Kathrin Plitzko2Philipp Thiel3Lech-Gustav Milroy4Markus Kaiser5Luc Brunsveld6Christian Ottmann7Laboratory of Chemical Biology and Institute for Complex Molecular Systems (ICMS), Department of Biomedical Engineering, Eindhoven University of TechnologyLaboratory of Chemical Biology and Institute for Complex Molecular Systems (ICMS), Department of Biomedical Engineering, Eindhoven University of TechnologyChemical Biology, Center of Medical Biotechnology, Faculty of Biology, University of Duisburg-EssenInstitute for Biomedical Informatics and Medical Informatics, University of TübingenLaboratory of Chemical Biology and Institute for Complex Molecular Systems (ICMS), Department of Biomedical Engineering, Eindhoven University of TechnologyChemical Biology, Center of Medical Biotechnology, Faculty of Biology, University of Duisburg-EssenLaboratory of Chemical Biology and Institute for Complex Molecular Systems (ICMS), Department of Biomedical Engineering, Eindhoven University of TechnologyLaboratory of Chemical Biology and Institute for Complex Molecular Systems (ICMS), Department of Biomedical Engineering, Eindhoven University of TechnologySmall molecule stabilizers of protein–protein interactions hold great therapeutic potential. Based on virtual screening and molecular docking, the authors here develop a strategy to evolve weak, promiscuous inhibitors of 14-3-3 interactions into selective stabilizers of the 14-3-3/ChREBP complex.https://doi.org/10.1038/s41467-020-17741-0
collection DOAJ
language English
format Article
sources DOAJ
author Eline Sijbesma
Emira Visser
Kathrin Plitzko
Philipp Thiel
Lech-Gustav Milroy
Markus Kaiser
Luc Brunsveld
Christian Ottmann
spellingShingle Eline Sijbesma
Emira Visser
Kathrin Plitzko
Philipp Thiel
Lech-Gustav Milroy
Markus Kaiser
Luc Brunsveld
Christian Ottmann
Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactions
Nature Communications
author_facet Eline Sijbesma
Emira Visser
Kathrin Plitzko
Philipp Thiel
Lech-Gustav Milroy
Markus Kaiser
Luc Brunsveld
Christian Ottmann
author_sort Eline Sijbesma
title Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactions
title_short Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactions
title_full Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactions
title_fullStr Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactions
title_full_unstemmed Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactions
title_sort structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactions
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2020-08-01
description Small molecule stabilizers of protein–protein interactions hold great therapeutic potential. Based on virtual screening and molecular docking, the authors here develop a strategy to evolve weak, promiscuous inhibitors of 14-3-3 interactions into selective stabilizers of the 14-3-3/ChREBP complex.
url https://doi.org/10.1038/s41467-020-17741-0
work_keys_str_mv AT elinesijbesma structurebasedevolutionofapromiscuousinhibitortoaselectivestabilizerofproteinproteininteractions
AT emiravisser structurebasedevolutionofapromiscuousinhibitortoaselectivestabilizerofproteinproteininteractions
AT kathrinplitzko structurebasedevolutionofapromiscuousinhibitortoaselectivestabilizerofproteinproteininteractions
AT philippthiel structurebasedevolutionofapromiscuousinhibitortoaselectivestabilizerofproteinproteininteractions
AT lechgustavmilroy structurebasedevolutionofapromiscuousinhibitortoaselectivestabilizerofproteinproteininteractions
AT markuskaiser structurebasedevolutionofapromiscuousinhibitortoaselectivestabilizerofproteinproteininteractions
AT lucbrunsveld structurebasedevolutionofapromiscuousinhibitortoaselectivestabilizerofproteinproteininteractions
AT christianottmann structurebasedevolutionofapromiscuousinhibitortoaselectivestabilizerofproteinproteininteractions
_version_ 1721215750068240384